Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 Velvet Velvet +26.11%
#4 Biconomy Biconomy +24.38%
#5 aPriori aPriori +22.89%
#6 Derive Derive +19.95%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Block Street Block Street +10.44%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
ANG Lifesciences India Limited ANG Lifesciences India Limited

ANG Lifesciences India Limited

ANG
株式のランク #35050
ANG Lifesciences India Ltd. specializes in the creation and distribution of... ANG Lifesciences India Ltd. specializes in the creation and distribution of finished pharmaceutical products, specifically sterile dry powder intended for injection vials. The company's diverse product line includes sterile dry powder vials for treatments such as antibiotics, anti-ulcer medications, glucocorticoids, anti-inflammatory agents, anti-malarial drugs, and anesthetics. Rajesh Gupta founded the company on June 14, 2006, and its main corporate office is situated in Amritsar, India.
株価
$0.34674726
最終同期: 2026-08-14
時価総額
$4.53M
変化（1日）
0.00%
変化（1年）
6.69%
国
IN
取引 ANG Lifesciences India Limited (ANG)

カテゴリー

Healthcare
ANG Lifesciences India Limited（ANG）の収益
Aug 2026 時点の収益 TTM: 0
ANG Lifesciences India Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
ANG Lifesciences India Limited の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US